Regeneron says half its COVID-19 treatment doses are being sent to 4 low-vaccination states


Health officials agree that if you are newly infected with COVID-19 and have an above-average risk of getting seriously ill, you should quickly seek treatment with Regeneron Pharmaceuticals' monoclonal antibody therapy. The federal government is covering the costs, some states have set up free infusion centers, and the antibody cocktail has been shown to reduce hospitalization rates by 70 percent for high-risk COVID-19 patients treated within 10 days.
"They are safe, they are free, they keep people out of the hospital and help keep them alive," Dr. Marcella Nunez-Smith, a senior adviser to the White House's COVID-19 response team, said at an Aug. 12 White House briefing.
But the loudest promotion of Regeneron's experimental treatment is coming from the governors of Texas and Florida, "where vaccinations lag and hospitalizations are soaring with Delta-variant infections" even as the governors "downplay vaccination and other measures that health officials say can prevent illness in the first place," Kaiser Health News reports. Texas Gov. Greg Abbott (R), who received Regeneron's lab-produced antibody cocktail earlier this month, on Wednesday banned government entities from requiring FDA-approved vaccinations.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The FDA approved Regeneron's treatment on an emergency use basis late last year, but few people used it as the vaccines became available and helped crush infections and hospitalizations. Then the Delta variant took hold. Since mid-July, Regeneron deliveries have "soared from 25,000 doses to 125,000 doses per week, with about half shipped to four states: Florida, Texas, Mississippi, and Alabama," Kaiser Health News reports, citing Regeneron spokeswoman Alexandra Bowie.
This "expensive, cumbersome, and difficult-to-use therapy" is "not a substitute for vaccine, by any means," Dr. Christian Ramers, an infectious disease specialist at Family Health Centers of San Diego, tells Kaiser Health News. "It's like playing defense with no offense."
Regeneron's infusions cost about $1,250 a dose, not counting the hundreds of dollars to transport the drug and administer the hour-long infusion, Kaiser Health News notes. "The federal government is also covering the costs of COVID vaccination, at about $20 a dose."
Both of those interventions are much less expensive than hospitalizing COVID-19 patients. But it's "fiscally irresponsible" and "downright despicable for 'small government conservatives' to look to the federal government to dole out the most extravagant rescues for their states when they've so willingly squandered — and impeded — the far more prudent and effective measures" like vaccines and masks, Neil J. Young writes at The Week.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr.: A new plan for sabotaging vaccines
Feature The Health Secretary announced changes to vaccine testing and asks Americans to 'do your own research'
-
Unraveling autism: RFK Jr.'s vow to find a root cause
Feature RFK Jr. has vowed to find the root cause of the 'autism epidemic' in months. Scientists have doubts.
-
The sneaking rise of whooping cough
Under the Radar The measles outbreak isn't the only one to worry about
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths